EDITORIAL
Published on 29 Aug 2022
Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
doi 10.3389/fphar.2022.997618
- 798 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Antimycobacterial Drug Discovery: Molecular Therapeutics and Target Identification
Antimycobacterial Drug Discovery: Molecular Therapeutics and Target Identification
6,768
Total downloads
28k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 03 Jan 2022
Identification of Novel Chemical Scaffolds that Inhibit the Growth of Mycobacterium tuberculosis in Macrophages
doi 10.3389/fphar.2021.790583
- 1,994 views
- 9 citations
ORIGINAL RESEARCH
Published on 09 Dec 2021
Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
doi 10.3389/fphar.2021.781640
- 3,306 views
- 6 citations
ORIGINAL RESEARCH
Published on 08 Dec 2021
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
doi 10.3389/fphar.2021.790767
- 3,826 views
- 23 citations
ORIGINAL RESEARCH
Published on 17 Nov 2021
Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
doi 10.3389/fphar.2021.746496
- 5,522 views
- 21 citations
REVIEW
Published on 30 Aug 2021
Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
doi 10.3389/fphar.2021.724725
- 8,114 views
- 19 citations
ORIGINAL RESEARCH
Published on 25 Jun 2021
Identification of the Target for a Transition Metal-α-Amino Acid Complex Antibiotic Against Mycobacterium smegmatis
doi 10.3389/fphar.2021.686358
- 908 views
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 28kTopic views
- 20kArticle views
- 6,768Article downloads